VBI-1901 shows promise in glioblastoma interim study
Slightly above 67% of VBI Vaccines' investor base is looking to short. The analysis of current outlook of investing in VBI Vaccines suggests that many traders are alarmed regarding VBI Vaccines' prospects. VBI Vaccines' investing sentiment can be driven by a variety of factors including economic data, VBI Vaccines' earnings reports, geopolitical events, and overall market trends.
VBI |
VBI-1901 shows promise in glioblastoma interim study
Read at investing.com
VBI Vaccines Fundamental Analysis
We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
VBI Vaccines is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
VBI Vaccines Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.
Peers
VBI Vaccines Related Equities
ANVS | Annovis Bio | 12.33 | ||||
ALLO | Allogene Therapeutics | 7.18 | ||||
JAGX | Jaguar Animal | 5.10 | ||||
BBIO | BridgeBio Pharma | 4.83 | ||||
IBIO | Ibio | 2.54 | ||||
GOVX | GeoVax Labs | 2.26 | ||||
VXRT | Vaxart | 1.67 | ||||
ARDX | Ardelyx | 1.31 | ||||
AKRO | Akero Therapeutics | 0.67 | ||||
AUPH | Aurinia Pharmaceuticals | 0.34 | ||||
TNXP | Tonix Pharmaceuticals | 2.50 | ||||
OCGN | Ocugen | 2.70 | ||||
ANIX | Anixa Biosciences | 4.09 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |